Erbin was previously shown to interact with HER2 and to influence cellular proliferation and tumorigenesis in the MMTV-neu transgenic mouse model of HER2 overexpressing breast cancer (Fig. 2G) [26, 27]. Here, ERBB2 is linked to breast carcinoma.